Meeting
2021 ASCO Annual Meeting
Multimodal profiling of biliary tract cancers to detect potentially actionable biomarkers and differences in immune signatures between subtypes.
Authors
Kabir Mody
Mayo Clinic, Jacksonville, FL
Kabir Mody , Nilofer Saba Azad , Prerna Jain , Sherif El-Refai , Rachna T. Shroff , Robin Kate Kelley , Anthony B. El-Khoueiry , Denise Lau , Gregory B. Lesinski , Mark Yarchoan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4023)
DOI
10.1200/JCO.2021.39.15_suppl.4023
Abstract #
4023
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Integrative whole exome, transcriptome, and clinical profiling of biliary tract cancers (BTCs).
First Author: Nguyen H. Tran
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
First Author: Milind M. Javle